Reviva Pharmaceuticals Holdings, Inc.
RVPH
$0.55
-$0.04-6.26%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 95.93% | -60.75% | 142.43% | -10.03% | -48.40% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -53.36% | -19.81% | -3.54% | 18.63% | -30.74% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 72.84% | -57.39% | 115.61% | -5.85% | -46.41% |
|
|
|||||
| Total Current Assets | 72.84% | -57.39% | 115.61% | -5.85% | -46.41% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | -- |
| Total Assets | 64.40% | -54.35% | 103.19% | -5.25% | -40.34% |
|
|
|||||
| Total Accounts Payable | 5.25% | -24.87% | -28.42% | 87.02% | -17.95% |
| Total Accrued Expenses | -0.13% | -17.37% | -10.74% | -4.11% | 6.64% |
| Short-term Debt | -49.53% | -51.05% | 452.05% | -60.00% | -37.50% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 91.05% | -3.54% | 16.74% | -3.73% | 18.02% |
| Total Other Current Liabilities | 91.05% | -3.54% | 16.74% | -3.73% | 18.02% |
| Total Current Liabilities | 4.94% | -21.18% | -16.72% | 25.75% | -3.78% |
|
|
|||||
| Total Current Liabilities | 4.94% | -21.18% | -16.72% | 25.75% | -3.78% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -49.53% | -51.05% | 452.05% | -60.00% | -37.50% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -39.93% | -68.76% | 14.25% | -48.14% | -57.15% |
| Total Liabilities | 4.83% | -21.47% | -16.59% | 24.96% | -5.04% |
|
|
|||||
| Common Stock & APIC | 6.05% | 0.70% | 11.52% | 3.08% | 2.25% |
| Retained Earnings | -3.55% | -3.92% | -3.96% | -5.59% | -5.54% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 89.71% | -648.86% | 108.14% | -65.22% | -348.92% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 89.71% | -648.86% | 108.14% | -65.22% | -348.92% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 89.71% | -648.86% | 108.14% | -65.22% | -348.92% |
|
|
|||||